E. Krystek

573 total citations
9 papers, 481 citations indexed

About

E. Krystek is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, E. Krystek has authored 9 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in E. Krystek's work include RNA and protein synthesis mechanisms (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Mitochondrial Function and Pathology (2 papers). E. Krystek is often cited by papers focused on RNA and protein synthesis mechanisms (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Mitochondrial Function and Pathology (2 papers). E. Krystek collaborates with scholars based in Austria, Germany and United States. E. Krystek's co-authors include Horst Ahorn, Ingrid Maurer-Fogy, Tilman Voss, Günther R. Adolf, Karl Pummer, Kurt Zatloukal, Christoph Klade, G Loeber, Anthony A. Infante and Mark B. Dworkin and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

E. Krystek

9 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Krystek Austria 8 345 85 73 70 63 9 481
M. Di Vito Italy 11 271 0.8× 55 0.6× 93 1.3× 41 0.6× 136 2.2× 11 495
Julio E. Celis Denmark 9 466 1.4× 108 1.3× 20 0.3× 44 0.6× 61 1.0× 9 585
R. Maschler Germany 14 333 1.0× 51 0.6× 55 0.8× 18 0.3× 48 0.8× 26 636
Frank Schumann Germany 9 396 1.1× 99 1.2× 54 0.7× 21 0.3× 22 0.3× 11 613
Darrin A. Lindhout Canada 14 561 1.6× 72 0.8× 24 0.3× 132 1.9× 23 0.4× 21 831
John Tra United States 6 538 1.6× 87 1.0× 41 0.6× 22 0.3× 40 0.6× 7 739
George Shaw United States 9 351 1.0× 89 1.0× 36 0.5× 53 0.8× 15 0.2× 21 651
Frédéric Villard Switzerland 10 269 0.8× 88 1.0× 30 0.4× 19 0.3× 83 1.3× 14 504
Lori Andrews United States 12 550 1.6× 39 0.5× 33 0.5× 13 0.2× 90 1.4× 13 708
Annie Bouchard Canada 16 750 2.2× 52 0.6× 13 0.2× 56 0.8× 43 0.7× 22 914

Countries citing papers authored by E. Krystek

Since Specialization
Citations

This map shows the geographic impact of E. Krystek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Krystek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Krystek more than expected).

Fields of papers citing papers by E. Krystek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Krystek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Krystek. The network helps show where E. Krystek may publish in the future.

Co-authorship network of co-authors of E. Krystek

This figure shows the co-authorship network connecting the top 25 collaborators of E. Krystek. A scholar is included among the top collaborators of E. Krystek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Krystek. E. Krystek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Klade, Christoph, Tilman Voss, E. Krystek, et al.. (2001). Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. PROTEOMICS. 1(7). 890–898. 158 indexed citations
2.
Klade, Christoph, Tilman Voss, E. Krystek, et al.. (2001). Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. PROTEOMICS. 1(7). 890–898. 11 indexed citations
3.
Sommergruber, Wolfgang, Horst Ahorn, Hannes Klump, et al.. (1994). 2A Proteinases of Coxsackie- and Rhinovirus Cleave Peptides Derived from eIF-4γ via a Common Recognition Motif. Virology. 198(2). 741–745. 80 indexed citations
4.
Voss, Tilman, Horst Ahorn, E. Krystek, et al.. (1994). Periplasmic expression of human interferon-α 2c in Escherichia coli results in a correctly folded molecule. Biochemical Journal. 298(3). 719–725. 12 indexed citations
5.
Loeber, G, Anthony A. Infante, Ingrid Maurer-Fogy, E. Krystek, & Mark B. Dworkin. (1991). Human NAD(+)-dependent mitochondrial malic enzyme. cDNA cloning, primary structure, and expression in Escherichia coli.. Journal of Biological Chemistry. 266(5). 3016–3021. 87 indexed citations
6.
Hauptmann, Rudolf, et al.. (1989). Vascular anticoagulant β: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. European Journal of Biochemistry. 185(1). 63–71. 78 indexed citations
7.
Krystek, E. & H.W. Hofer. (1981). Interaction of a phosphorylated site of muscle phosphofructokinase with the activation of the enzyme by and K+. Biochemical and Biophysical Research Communications. 99(4). 1138–1145. 6 indexed citations
8.
Hofer, H.W. & E. Krystek. (1975). Determination of the kinetic parameters of phosphofructokinase dissociation. FEBS Letters. 53(2). 217–220. 21 indexed citations
9.
Eyer, Peter, Hans Werner Hofer, E. Krystek, & Dirk Pette. (1971). Synthesis of Glucose 1,6‐Bisphosphate by the Action of Crystalline Rabbit Muscle Phosphofructokinase. European Journal of Biochemistry. 20(2). 153–159. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026